Medical specialists from Swaziland tagged by Regulatory Authorities as investigators in clinical studies for the listed conditions:
C
Sponsors and Collaborators
- Julian Taylor Green
- Rivierduinen, Centre for Personality disorders Jelgersma
- University of Applied Sciences Jena
- Oblikue Consulting
- Plethora Solutions Ltd
- Korea Otsuka International Asia Arab
- Foundation for Biosanitary Research and Innovation in Primary Health Care
- Eurotrials Brasil Consultores Cientificos Ltda
- Foshan Sanshui District People's Hospital
- Arsha Vidya Tirtha
- Paulo Sérgio Gomes Nogueira Borges
- Lilly PharmaceuticalCompany
- 904 Hospital of the People's Liberation Army Joint Logistic Support Force
- Iyad Naeem Muhammad, PhD
- Cardiovascular Center Dedinje, Belgrade, Serbia
- Sudimplant SAS - Groupe TBR
- Klinik für Allgemein- und Viszeralchirurgie, Department Chirurgie, Luzerner Kantonsspital
- United States Department of Defense (DOD)
- S-Biotek Holding ApS
- Gunkang Pharmaceuticals, Inc
- View Full List
Medical Conditions
- Screening Compliance
- Monogenic Lupus
- Outcome After Hepatectomy
- Traumatic Encephalopathy, Chronic
- Correction of the Moderate to Severe Nasolabial Folds
- Glottic Web of Larynx
- Bowel Preparation Before Colonoscopy
- Keratoplasty
- Hidden Blood Loss
- Raynaud Phenomena
- Homologous Recombination Deficiency Alterations Metastatic Colorectal Cancer
- HoFH
- SCLC
- Spinocerebellar Ataxia 29
- Metastatic Platinum-Resistant Ovarian Carcinoma
- HOMA-IR
- Developmental Dislocation of Hip
- Symptomatic Supraventricular Tachycardia
- Showing the Results of a Program of NHS in Cuiaba_ Brazil
- Coccyx Injury
- View Full List
Drug Interventions
- Ebselen
- Mineralocorticoid receptor antagonist
- Celecoxib
- ABY-035 i.v.
- Oxycodone
- Acalabrutinib in combination with VR
- Sorafenib
- Pegfilgrastim
- Recombinant monoclonal antibody against human epidermal growth factor receptor injection (HS627)
- Pemetrexed
- Bimatoprost 0.03% eye drops
- F520
- Cyanoacrylate
- S-Adenosyl-Methionine
- Cytisine
- MMV390048 120mg
- Furmonertinib 160 mg
- Vosaroxin
- Standard medical therapy
- Rovalpituzumab tesirine
- View Full List
CROs by country
- Contract Research Organizations in Argentina
- Contract Research Organizations in Armenia
- Contract Research Organizations in Burkina Faso
- Contract Research Organizations in Hong Kong
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Myanmar
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in Poland
- Contract Research Organizations in Rwanda
- Contract Research Organizations in Slovenia
- Contract Research Organizations in Sweden
- Contract Research Organizations in Uganda
- Contract Research Organizations in United States
- CRO list by country